Clopidogrel Oxidative (Impurity-F)
| Product Name | Clopidogrel Oxidative (Impurity-F) |
|---|---|
| Alternate Names | Clopidogrel Impurities, Impurities of Clopidogrel |
| CAT No. | CS-EO-01036 |
| CAS No. | 1030894-82-6 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 320.81 g/mol |
| Mol. For. | C₁₆H₁₅ClNO₂S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Clopidogrel |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Clopidogrel is a drug that belongs to the class of antiplatelet agents. It is used to prevent blood clots in people with conditions such as heart attack, stroke, and peripheral artery disease. Clopidogrel Oxidative (Impurity-F) is a chemical impurity that is formed during the manufacturing process of clopidogrel. It is important to monitor and control the levels of impurities in pharmaceutical products as they can affect the safety and efficacy of the drug.
Chemically, clopidogrel oxidative (Impurity-F) is a derivative of the parent compound clopidogrel. It is a yellowish-brown solid that is slightly soluble in water and ethanol. The chemical formula of clopidogrel oxidative (Impurity-F) is C16H16ClNO2S.
The presence of impurities in pharmaceutical products can lead to adverse effects on the patient. Therefore, it is essential to control the levels of clopidogrel oxidative (Impurity-F) in the final product. The acceptable limit of this impurity in clopidogrel is 0.1% as per the International Conference on Harmonisation (ICH) guidelines.
In conclusion, clopidogrel oxidative (Impurity-F) is an impurity that is formed during the manufacturing process of clopidogrel. The presence of this impurity can affect the safety and efficacy of the drug. Therefore, it is important to monitor and control the levels of impurities in pharmaceutical products.
Get an Instant Quote
Related Compounds
Ethyl-S-(+)-Clopidogrel Sulfate | rac-Clopidogrel Carboxylic Acid | rac-Clopidogrel Iminium bromide Impurity | cis-Clopidogrel Glutathione Disulfide | Clopidogrel Sulfonated Impurity | Clopidogrel Hydroxy Impurity | Clopidogrel Cyano Racemate | Clopidogrel Impurity 7 | Clopidogrel Thienylethyl Impurity | rac-Clopidogrel Iminium Impurity | Clopidogrel Impurity B | Clopidogrel EP Impurity C | Clopidogrel 3-Sulfonated Impurity | Clopidogrel Impurity 3 | Clopidogrel EP Impurity E | Clopidogrel Pyridinium Bromide Impurity | Open Ring N-Methyl Clopidogrel Hydrochloride | Clopidogrel Impurity 30 | Clopidogrel EP Impurity D | Clopidogrel carboxylic acid HCl Salt | Clopidogrel R-Isomer | Clopidogrel EP Impurity B Hydrochloride | Clopidogrel Impurity CHOX | Clopidogrel EP Impurity A | Clopidogrel Ethyl Ester Analog (HCl Salt) | Clopidogrel EP Impurity B Hydrochloride | Clopidogrel Open Ring R-enantiomer | N-Methyl Clopidogrel Impurity I | methyl 2-(2-chlorophenyl)-2-(4,5-dihydrothieno[2,3-c]pyridin-6(7H)-yl)acetate heminaphthalene-1,5-di | Clopidogrel Impurity D Sulfate | rac Clopidogrel [(tert-Butylcarbonyl)oxy]methyl Ester | Clopidogrel Pyridinium Bromide Impurity | R-Clopidogrel Carboxylic Acid | Ticlopidine Pyridinium Bromide | rac-Clopidogrel-MP Endo Derivative | Clopidogrel Besylate | Clopidogrel 2-Methoxysulphonyl impurity | cis-Clopidogrel-MP Derivative (Pair of Enantiomers) | Clopidogrel EP Impurity-B |